nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—FDPS—jaw skeleton—Parkinson's disease	0.102	0.107	CbGeAlD
Alendronate—PTPN4—hindbrain—Parkinson's disease	0.0672	0.0706	CbGeAlD
Alendronate—PTPRS—hindbrain—Parkinson's disease	0.0576	0.0605	CbGeAlD
Alendronate—PTPN4—brainstem—Parkinson's disease	0.0385	0.0405	CbGeAlD
Alendronate—ATP6V1A—hindbrain—Parkinson's disease	0.0332	0.0349	CbGeAlD
Alendronate—PTPRE—cardiovascular system—Parkinson's disease	0.033	0.0347	CbGeAlD
Alendronate—PTPRS—brainstem—Parkinson's disease	0.033	0.0347	CbGeAlD
Alendronate—PTPRS—forebrain—Parkinson's disease	0.0319	0.0335	CbGeAlD
Alendronate—PTPRE—midbrain—Parkinson's disease	0.0258	0.0271	CbGeAlD
Alendronate—PTPRE—head—Parkinson's disease	0.0224	0.0235	CbGeAlD
Alendronate—PTPN4—head—Parkinson's disease	0.0213	0.0224	CbGeAlD
Alendronate—PTPRE—nervous system—Parkinson's disease	0.0212	0.0223	CbGeAlD
Alendronate—ATP6V1A—embryo—Parkinson's disease	0.0208	0.0218	CbGeAlD
Alendronate—PTPRS—spinal cord—Parkinson's disease	0.0205	0.0216	CbGeAlD
Alendronate—PTPRE—central nervous system—Parkinson's disease	0.0204	0.0215	CbGeAlD
Alendronate—PTPN4—nervous system—Parkinson's disease	0.0202	0.0212	CbGeAlD
Alendronate—PTPRE—cerebellum—Parkinson's disease	0.02	0.021	CbGeAlD
Alendronate—PTPN4—central nervous system—Parkinson's disease	0.0194	0.0204	CbGeAlD
Alendronate—ATP6V1A—brainstem—Parkinson's disease	0.019	0.02	CbGeAlD
Alendronate—PTPN4—cerebellum—Parkinson's disease	0.019	0.02	CbGeAlD
Alendronate—ATP6V1A—forebrain—Parkinson's disease	0.0184	0.0193	CbGeAlD
Alendronate—PTPRS—head—Parkinson's disease	0.0182	0.0192	CbGeAlD
Alendronate—PTPRS—nervous system—Parkinson's disease	0.0173	0.0182	CbGeAlD
Alendronate—PTPRS—central nervous system—Parkinson's disease	0.0167	0.0175	CbGeAlD
Alendronate—PTPRS—cerebellum—Parkinson's disease	0.0163	0.0171	CbGeAlD
Alendronate—PTPRE—brain—Parkinson's disease	0.0162	0.017	CbGeAlD
Alendronate—PTPN4—brain—Parkinson's disease	0.0154	0.0162	CbGeAlD
Alendronate—FDPS—forebrain—Parkinson's disease	0.0138	0.0145	CbGeAlD
Alendronate—ATP6V1A—medulla oblongata—Parkinson's disease	0.0133	0.0139	CbGeAlD
Alendronate—PTPRS—brain—Parkinson's disease	0.0132	0.0139	CbGeAlD
Alendronate—ATP6V1A—midbrain—Parkinson's disease	0.0121	0.0127	CbGeAlD
Alendronate—ATP6V1A—spinal cord—Parkinson's disease	0.0118	0.0124	CbGeAlD
Alendronate—FDPS—cardiovascular system—Parkinson's disease	0.0117	0.0123	CbGeAlD
Alendronate—ATP6V1A—head—Parkinson's disease	0.0105	0.0111	CbGeAlD
Alendronate—FDPS—medulla oblongata—Parkinson's disease	0.01	0.0105	CbGeAlD
Alendronate—ATP6V1A—nervous system—Parkinson's disease	0.00997	0.0105	CbGeAlD
Alendronate—ATP6V1A—central nervous system—Parkinson's disease	0.0096	0.0101	CbGeAlD
Alendronate—ATP6V1A—cerebellum—Parkinson's disease	0.00939	0.00986	CbGeAlD
Alendronate—FDPS—midbrain—Parkinson's disease	0.00914	0.0096	CbGeAlD
Alendronate—FDPS—spinal cord—Parkinson's disease	0.00892	0.00937	CbGeAlD
Alendronate—FDPS—head—Parkinson's disease	0.00792	0.00833	CbGeAlD
Alendronate—ATP6V1A—brain—Parkinson's disease	0.00762	0.00801	CbGeAlD
Alendronate—FDPS—nervous system—Parkinson's disease	0.00751	0.00789	CbGeAlD
Alendronate—FDPS—central nervous system—Parkinson's disease	0.00723	0.0076	CbGeAlD
Alendronate—FDPS—cerebellum—Parkinson's disease	0.00707	0.00743	CbGeAlD
Alendronate—FDPS—brain—Parkinson's disease	0.00574	0.00603	CbGeAlD
Alendronate—ATP6V1A—Insulin receptor recycling—INSR—Parkinson's disease	0.00531	0.11	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—CP—Parkinson's disease	0.00404	0.0838	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—HMOX1—Parkinson's disease	0.0024	0.0498	CbGpPWpGaD
Alendronate—ATP6V1A—Insulin receptor recycling—INS—Parkinson's disease	0.00235	0.0488	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—Parkinson's disease	0.00228	0.0474	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGF20—Parkinson's disease	0.0018	0.0373	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FGB—Parkinson's disease	0.00161	0.0334	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INSR—Parkinson's disease	0.00161	0.0334	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000996	0.0207	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000996	0.0207	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—INS—Parkinson's disease	0.000861	0.0179	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000712	0.0148	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INS—Parkinson's disease	0.000711	0.0148	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—VPS35—Parkinson's disease	0.000672	0.014	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MCCC1—Parkinson's disease	0.000625	0.013	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TALDO1—Parkinson's disease	0.000587	0.0122	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—OMD—Parkinson's disease	0.000587	0.0122	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CASP3—Parkinson's disease	0.000561	0.0117	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000528	0.011	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000486	0.0101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FBP1—Parkinson's disease	0.000473	0.00983	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TAF1—Parkinson's disease	0.000473	0.00983	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VPS35—Parkinson's disease	0.000471	0.00977	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000444	0.00922	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MCCC1—Parkinson's disease	0.000418	0.00868	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ND3—Parkinson's disease	0.000418	0.00868	CbGpPWpGaD
Alendronate—FDPS—Metabolism—OMD—Parkinson's disease	0.000393	0.00816	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TALDO1—Parkinson's disease	0.000393	0.00816	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GPR37—Parkinson's disease	0.00039	0.0081	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DGKQ—Parkinson's disease	0.00039	0.0081	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SNCA—Parkinson's disease	0.000378	0.00786	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL6—Parkinson's disease	0.000378	0.00786	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NDUFB11—Parkinson's disease	0.000373	0.00774	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000357	0.0074	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCH1—Parkinson's disease	0.000356	0.00738	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000346	0.00719	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000333	0.00691	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000321	0.00666	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FBP1—Parkinson's disease	0.000317	0.00658	CbGpPWpGaD
Alendronate—FDPS—Metabolism—DBH—Parkinson's disease	0.000317	0.00658	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GBA—Parkinson's disease	0.000317	0.00658	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RIT2—Parkinson's disease	0.000312	0.00647	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—Parkinson's disease	0.000311	0.00645	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRK5—Parkinson's disease	0.000295	0.00614	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000289	0.006	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL14—Parkinson's disease	0.000287	0.00596	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL23A—Parkinson's disease	0.000287	0.00596	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000278	0.00576	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPS8—Parkinson's disease	0.000268	0.00555	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF20—Parkinson's disease	0.000268	0.00555	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM4—Parkinson's disease	0.000265	0.0055	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PENK—Parkinson's disease	0.000251	0.00522	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAG—Parkinson's disease	0.000251	0.00522	CbGpPWpGaD
Alendronate—FDPS—Metabolism—DDC—Parkinson's disease	0.000233	0.00483	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDYN—Parkinson's disease	0.00023	0.00477	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA4—Parkinson's disease	0.00022	0.00456	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000217	0.0045	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GFAP—Parkinson's disease	0.000216	0.00449	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRM5—Parkinson's disease	0.000214	0.00444	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLA2G6—Parkinson's disease	0.000198	0.00411	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADRBK1—Parkinson's disease	0.000197	0.00408	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MAOB—Parkinson's disease	0.000196	0.00407	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HSPA1A—Parkinson's disease	0.000195	0.00405	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF20—Parkinson's disease	0.000187	0.00389	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000186	0.00387	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000182	0.00377	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INSR—Parkinson's disease	0.000168	0.00348	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGB—Parkinson's disease	0.000158	0.00329	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000158	0.00327	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TAC1—Parkinson's disease	0.000155	0.00322	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DRD1—Parkinson's disease	0.000152	0.00316	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DRD3—Parkinson's disease	0.000147	0.00306	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2D6—Parkinson's disease	0.000146	0.00302	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CTGF—Parkinson's disease	0.000143	0.00297	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000138	0.00286	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DRD2—Parkinson's disease	0.000133	0.00277	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR7—Parkinson's disease	0.000133	0.00277	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—Parkinson's disease	0.000133	0.00276	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2E1—Parkinson's disease	0.000133	0.00276	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NQO1—Parkinson's disease	0.000132	0.00273	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TH—Parkinson's disease	0.00013	0.00269	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYCS—Parkinson's disease	0.000125	0.00259	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—Parkinson's disease	0.000124	0.00257	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF2—Parkinson's disease	0.000112	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COMT—Parkinson's disease	0.00011	0.00229	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—Parkinson's disease	0.00011	0.00228	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MAOA—Parkinson's disease	0.00011	0.00227	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—Parkinson's disease	0.000108	0.00225	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000108	0.00224	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDN1—Parkinson's disease	0.000107	0.00222	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—Parkinson's disease	0.000106	0.0022	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCB1—Parkinson's disease	0.000104	0.00216	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—Parkinson's disease	0.000101	0.00209	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGF—Parkinson's disease	9.81e-05	0.00204	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—Parkinson's disease	9.66e-05	0.00201	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR2A—Parkinson's disease	9.34e-05	0.00194	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—Parkinson's disease	8.92e-05	0.00185	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—Parkinson's disease	8.68e-05	0.0018	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—Parkinson's disease	8.3e-05	0.00172	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—Parkinson's disease	7.42e-05	0.00154	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—Parkinson's disease	7.09e-05	0.00147	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—Parkinson's disease	5.52e-05	0.00115	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—Parkinson's disease	5.07e-05	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—Parkinson's disease	4.63e-05	0.000961	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—Parkinson's disease	3.24e-05	0.000673	CbGpPWpGaD
